期刊文献+

B7-H4蛋白在上皮性卵巢癌中的表达及临床意义

EXPRESSION OF B7-H4 PROTEIN IN OVARIAN EPITHELIAL CANCER AND ITS CLINICAL SIGNIFICANCE
下载PDF
导出
摘要 目的探讨B7-H4蛋白在上皮性卵巢肿瘤中的表达及临床意义。方法用链毒菌抗生物素蛋白过氧化物酶免疫组织化学染色的方法检测B7-H4蛋白在正常卵巢、良性上皮性卵巢肿瘤、交界性上皮性卵巢肿瘤、上皮性卵巢癌组织中的表达,并分析其与各临床病理特征的关系。结果 B7-H4蛋白在卵巢癌组阳性表达率显著高于正常组、良性组、交界组,差异有统计学意义(P<0.01),其余各组间差异无统计学意义(P>0.05)。B7 H4的表达与病理分期、分级、类型相关,差异有统计学意义(P<0.05)。上皮性卵巢癌分期越晚、分化越差B7 H4表达越高,浆液性癌B7-H4表达高于黏液性癌。结论 B7-H4在卵巢癌中的高表达及其与病理类型、临床分级、分期的关系,提示其可能与肿瘤发生发展有关,可为卵巢恶性肿瘤诊断及治疗提供靶位点。 Objective To investigate the expression of B7-H4 protein in ovarian tumors and its clinical significance. Methods The expression of BT-H4 protein was detected by immunohistochemical streptavidin-peroxidase (SP) method in normal ovarian tissues, benign epithelial ovarian tumors, borderline ovarian tumors and ovarian carcinoma. The relationship between BT-H4 protein and pathological feature was analyzed. Results The positive expression rate of BT-H4 protein in ovarian carcinoma group was higher than normal, benign, and borderline group (P〈 0.01). No significantly statistical difference was found between other two-two comparisons (P 〉 0.05). The expression of BT-H4 protein Was correlated with pathological stage,grade and type (P 〈0.05). Tissues from ovarian carcinoma of late stage and poor differentiation presented with increased B7-H4 protein expression, the positive expression rate of BT-H4 protein in serous cystadenocarcinoma was higher than mucinous cystadenocarcinoma. Conclusion The up-regulation of B7-H4 protein in ovarian carcinoma has positive relationship with late stage and lower grade,reveals that B7-H4 may play an important role in the genisis and development of ovarian cancer. The detection of B7-H4 protein expression may be helpful in malignant ovarian tumor diagnosis and treatment.
出处 《河北医科大学学报》 CAS 2010年第3期291-293,313,共4页 Journal of Hebei Medical University
关键词 B7-H4蛋白 卵巢肿瘤 免疫组织化学 B7-H4 protein ovarian neoplasms immunohistochemistry
  • 相关文献

参考文献9

  • 1SICA GL,CHOI IH,ZHU G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18(6):849-861.
  • 2PRASAD DV,RICHARDS S,MAI XM,et al.B7S1,a novel B7 family member that negatively regulates T cell activation[J].Immunity,2003,18(6):863-873.
  • 3ORDONEZ NG.Aplication of mesothelin immunostaining in tumor diagnosis[J].Am J Surg Pathol,2003,27(11):1418-1428.
  • 4KRYCZEK I,WEI S,ZHU G,et al.Relationship between B7-H4,regulatory T cells,and patient outcome in human ovarian carcinoma[J].Cancer Res,2007,67(18):8900-8905.
  • 5SIMON I,LIU Y,KRALL KL,et al.Evaluation of the novel serum markers B7-H4,Spondin 2,and DcR3 for diagnosis and early detection of ovarian cancer[J].Gynecol Oncol,2007,106(1):112-118.
  • 6OIKONOMOPOULOU K,ZHENG Y,LI L,et al.Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel[J].Br J Cancer,2008,99(7):1103-1113.
  • 7THOMPSON RH,ZANG X,LOHSE CM,et al.Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage[J].Cancer Res,2008,68(15):6054-6058.
  • 8SUN Y,WANG Y,WANG X,et al.B7-H3 and B7-H4 expression in non-small-cell lung cancer[J].Lung Cancer,2006,53(2):143-151.
  • 9MIYATAKE T,TRINGLER B,LIU WH,et al.B7-H4(DD-O110) is over expressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell in-filtration[J].Gynecol Oncol,2007,106(1):119-127.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部